Brainstorm cell therapeutics inc. (BCLI)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net loss

-8,114

-

-5,634

-

-5,027

-

-3,176

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-4,900

-

-

-

-3,091

-2,298

276

-2,403

-1,040

-1,785

-624

-1,606

-962

-1,790

-1,384

-2,603

-2,265

-2,236

-2,730

-2,421

-1,984

-2,111

-1,217

-1,082

-1,518

-1,082

-578

-1,150

-830

-872

-5,026

-694

2,507

-705

Less - loss for the period from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

49

50

37

33

44

21

33

31

25

28

23

18

16

22

17

22

16

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

26

24

23

26

30

25

25

20

27

17

33

40

40

39

38

37

40

38

38

Severance pay, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

0

-

-

-

-

-

Severance pay, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

9

3

-27

-8

Accrued interest on loans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

3

0

0

Amortization of discount on short-term loans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Change in fair value of options and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

-

-

-

-

Shares and options granted to service providers

0

0

0

0

25

102

0

0

0

-

18

-

-

0

90

0

31

0

0

108

0

12

76

0

110

14

11

74

128

-

-

-

-

-

-

-

-

Change in fair value of options and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Expenses related to shares and options granted to service providers

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38

4

4

203

24

242

-20

Deferred Stock-based compensation related to options granted to employees and directors

390

182

217

53

312

319

235

136

227

156

215

57

126

-1

171

262

203

-120

287

321

347

446

280

176

122

235

-75

311

203

120

127

136

177

-

343

-

-

Finance lease expense (income)

-85

-

-

-

94

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in other accounts expenses and other current assets

2,078

-

-

-

1,449

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in lease liability

-

-

49

44

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease (increase) in other accounts receivable and prepaid expenses

-

-

-290

801

-

1,203

-670

-411

116

2,842

-561

587

-76

262

-1,140

768

-269

-85

552

-362

-309

-

-341

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation related to options granted to employees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

416

27

Decrease (increase) in accounts receivable and prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

53

-117

386

-198

95

-128

305

-56

-72

249

-26

172

14

-265

Increase (decrease) in trade payables

-10,106

5,533

379

3,736

481

1,946

-1,580

921

1,837

1,149

48

-135

17

-7

-3

74

-888

834

-420

-167

-620

238

547

431

98

-218

73

127

-112

164

-321

190

81

85

-137

-105

94

Increase in deferred grant income

0

-

0

-511

511

-130

-1,755

683

-1,423

-2,625

5,250

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in other accounts payable and accrued expenses

759

-1,100

1,036

-1,162

1,276

605

-1,021

964

-378

879

131

57

-92

-324

-84

-34

-822

-720

732

-33

233

480

66

-256

177

118

135

21

32

-280

131

-30

74

242

-307

-253

254

Revaluation of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

7

19

-38

691

1,071

-174

0

0

0

-

-

-

-

-

-

-

-

Erosion of restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Total net cash provided by (used in) operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-275

-1,406

-2,981

-1,291

-2,530

-1,650

-1,937

-

-1,119

-970

-

-

-

-

-670

-696

-1,074

-419

-746

-471

-897

-800

-55

Net cash used in discontinued operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Total net cash used in operating activities

-15,029

-3,278

-3,626

-3,508

-835

-3,723

-6,594

55

-2,126

-2,935

3,843

-1,630

-1,642

-

-

-

-

-

-

-

-

-

-

-

-391

-1,608

-713

-1,063

-670

-696

-1,074

-419

-746

-471

-897

-800

-55

Cash flows from investing activities:
Purchase of property and equipment

7

346

102

21

4

108

1

215

45

62

86

32

0

7

11

59

26

49

12

-16

0

67

0

0

94

11

31

46

20

15

14

9

52

10

1

0

37

Changes in short-term deposit

1,987

-1

-1,541

-1,412

-3,135

-4,072

-4,983

12,818

-2,914

-2,810

7,150

-6,810

-1,700

-795

-299

-196

-4,794

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Changes in short-term deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,953

539

13,565

2,690

1,600

0

0

-4,786

3,006

8

-997

-

-

-

-

-

-

-

-

Changes in short-term deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Investment in lease deposit

-

-

0

0

-

-

-1

0

5

3

2

-2

1

0

2

0

2

-1

2

0

0

0

6

2

-9

-6

2

3

6

0

0

0

0

-8

0

-9

1

Proceeds from issuances of common stock through equity warrants and options exercises

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuances of common stock through equity warrants and options exercises

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

470

215

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of Common stock, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,348

-

-104

9,658

-

0

3,326

0

250

-5

5,028

0

0

0

-24

19

3,607

Net cash used in discontinued investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Total net cash provided by (used in) investing activities

-1,994

-345

1,439

1,391

3,131

3,968

4,983

-13,033

2,864

2,745

-7,238

6,780

1,699

-

-

-

-

-

-

-

-

-

-

-

-85

4,781

-3,039

-57

971

-2,765

-14

-9

-52

-18

-1

-9

-36

Cash flows from financing activities:
Total net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

286

137

4,766

898

1,939

-555

-13,565

-

-1,606

-2

-

-

-

-

971

-2,765

-14

-9

-52

-18

-1

-9

-36

Proceeds from exercise of options

29

0

30

5

0

0

0

0

25

209

75

30

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of shares in at-the-market (ATM) offering (Note 7)

18,972

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of shares and warrants in Registered Direct Offering (Note 7)

9,957

0

3,126

0

0

-

46

11,994

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from loans, notes and issuance of warrants, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

0

0

0

0

Proceeds from equity offering through issuances of equity warrants and common stock through the exercise of previously issued equity warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

12

12,397

0

0

0

0

1

0

7

0

0

0

126

20

22

413

25

55

Redemption of warrants in cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

600

0

-

0

0

-

-

-

-

-

-

-

-

-

Repayment of short-term loans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Total net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

111

0

12

14,745

-

366

9,273

-

-

-

-

250

-5

5,028

126

20

22

389

44

3,662

Net cash provided by discontinued financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Total net cash provided by financing activities

28,958

2,064

3,156

5

0

0

46

11,994

25

209

75

30

0

-

-

-

-

-

-

-

-

-

-

-

0

1

3,326

7

250

-5

5,028

126

20

22

389

44

3,662

Increase in cash and cash equivalents

11,935

-

969

-

2,296

-

-1,565

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-2,112

-

-

-

-984

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in cash and cash equivalents

-

-

-

-

-

-

-

-

763

19

-3,320

5,180

57

-408

11

-1,269

1,785

-282

-591

-2,193

-757

-4,718

-2,359

8,301

-476

3,174

-426

-1,113

551

-3,466

3,940

-302

-778

-467

-509

-765

3,571

Stock issued for warrants exchange

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

1,633

-

-

0

0

-

-

-

-

-

-

-

-

-

Exercise of liability classified warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

130

-84

0

42

0

-

0

0

-

-

-

-

-

-

-

-

-

Total non-cash financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

1,675

-

-

0

0

-

-

-

-

-

-

-

-

-

Conversion of convertible loan and convertible note to shares Conversion of trade payable to Common Stock $ 84

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

3

137

0

Conversion of other accounts payable to Common Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24

Conversion of a trade payable to Common Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-24

0

-113

137